BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24747064)

  • 1. Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.
    Santos K; Laranjo M; Abrantes AM; Brito AF; Gonçalves C; Sarmento Ribeiro AB; Botelho MF; Soares MI; Oliveira AS; Pinho e Melo TM
    Eur J Med Chem; 2014 May; 79():273-81. PubMed ID: 24747064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiral 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles with anti-breast cancer properties.
    Soares MI; Brito AF; Laranjo M; Paixão JA; Botelho MF; Pinho e Melo TM
    Eur J Med Chem; 2013 Feb; 60():254-62. PubMed ID: 23313634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral 6-hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: novel antitumor DNA monoalkylating agents.
    Soares MI; Brito AF; Laranjo M; Abrantes AM; Botelho MF; Paixão JA; Beja AM; Silva MR; Pinho E Melo TM
    Eur J Med Chem; 2010 Oct; 45(10):4676-81. PubMed ID: 20705366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents.
    Zhou W; Huang A; Zhang Y; Lin Q; Guo W; You Z; Yi Z; Liu M; Chen Y
    Eur J Med Chem; 2015; 96():269-80. PubMed ID: 25899332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor evaluation of novel benzo[d]pyrrolo[2,1-b]thiazole derivatives.
    Chaniyara R; Tala S; Chen CW; Lee PC; Kakadiya R; Dong H; Marvania B; Chen CH; Chou TC; Lee TC; Shah A; Su TL
    Eur J Med Chem; 2012 Jul; 53():28-40. PubMed ID: 22507893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile synthesis of novel substituted aryl-thiazole (SAT) analogs via one-pot multi-component reaction as potent cytotoxic agents against cancer cell lines.
    Mirza S; Asma Naqvi S; Mohammed Khan K; Salar U; Choudhary MI
    Bioorg Chem; 2017 Feb; 70():133-143. PubMed ID: 28038777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers.
    Jaiswal AS; Hirsch-Weil D; Proulx ER; Hong S; Narayan S
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4850-3. PubMed ID: 25240616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
    Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
    Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
    Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
    Giraud F; Akué-Gédu R; Nauton L; Candelon N; Debiton E; Théry V; Anizon F; Moreau P
    Eur J Med Chem; 2012 Oct; 56():225-36. PubMed ID: 22982527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents.
    Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P
    Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo.
    Carrasco E; Álvarez PJ; Melguizo C; Prados J; Álvarez-Manzaneda E; Chahboun R; Messouri I; Vázquez-Vázquez MI; Aránega A; Rodríguez-Serrano F
    Eur J Med Chem; 2014 May; 79():1-12. PubMed ID: 24704691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 3-(trimethoxyphenyl)-2(3H)-thiazole thiones as combretastatin analogs.
    Banimustafa M; Kheirollahi A; Safavi M; Kabudanian Ardestani S; Aryapour H; Foroumadi A; Emami S
    Eur J Med Chem; 2013; 70():692-702. PubMed ID: 24219991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiproliferative activity of 2,4-disubstituted 6-aryl-7H-pyrrolo[3,2-d]pyrimidin-7-one 5-oxides.
    Pudziuvelyte E; Ríos-Luci C; León LG; Cikotiene I; Padrón JM
    Bioorg Med Chem; 2009 Jul; 17(14):4955-60. PubMed ID: 19527934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
    Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
    Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
    Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity.
    Holla BS; Rao BS; Sarojini BK; Akberali PM
    Eur J Med Chem; 2004 Sep; 39(9):777-83. PubMed ID: 15337290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
    Al-Saadi MS; Rostom SA; Faidallah HM
    Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
    Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
    Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
    Bonham S; O'Donovan L; Carty MP; Aldabbagh F
    Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.